ARCHIVES

DCT Adopts New Unsolicited Contract Review Procedures

This article is from The Cancer Letter archive.

Vol. 02 No. 21 | May 21, 1976

Download PDF Visit The Full Archive

Related Articles

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

President Requests Extra $200 Million For NIH

March 7, 2014

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999